BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.64% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.2% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Midland States Bancorp
MSBI
$698M
| $106K | ﹤0.01% |
4,395
+4,389
| +73,150% | +$106K |
|
2977
TG Therapeutics
TGTX
$7.34B
| $105K | ﹤0.01% |
13,117
+9,255
| +240% | +$50K |
|
2978
SSR Mining
SSRM
$6.49B
| $105K | ﹤0.01% |
8,327
+27
| +0.3% | +$357 |
|
|
RRD
2979
DELISTED
RR Donnelley & Sons Co.
RRD
| $105K | ﹤0.01% |
22,308
+7,968
| +56% | +$41K |
|
|
RESI
2980
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $105K | ﹤0.01% |
11,280
+3,632
| +47% | +$37.9K |
|
2981
First Financial Corp
THFF
$975M
| $105K | ﹤0.01% |
2,489
+1,905
| +326% | +$80.8K |
|
|
TSC
2982
DELISTED
TriState Capital Holdings, Inc.
TSC
| $104K | ﹤0.01% |
5,106
+5,097
| +56,633% | +$108K |
|
2983
RadNet
RDNT
$6.08B
| $104K | ﹤0.01% |
8,399
+6,965
| +486% | +$91.4K |
|
|
GTS
2984
DELISTED
Triple-S Management Corporation
GTS
| $104K | ﹤0.01% |
4,787
+3,864
| +419% | +$78.6K |
|
2985
Monarch Casino & Resort
MCRI
$2.2B
| $104K | ﹤0.01% |
2,361
+2,149
| +1,014% | +$92.3K |
|
2986
Frontline
FRO
$9.02B
| $104K | ﹤0.01% |
16,036
+13,331
| +493% | +$79.2K |
|
2987
LeMaitre Vascular
LMAT
$1.87B
| $103K | ﹤0.01% |
3,337
+3,332
| +66,640% | +$88.9K |
|
2988
Peapack-Gladstone Financial
PGC
$822M
| $103K | ﹤0.01% |
3,941
+3,936
| +78,720% | +$108K |
|
|
ORBC
2989
DELISTED
ORBCOMM, Inc.
ORBC
| $103K | ﹤0.01% |
15,230
+15,204
| +58,477% | +$122K |
|
|
YRD
2990
Yiren Digital
YRD
$105M
| $103K | ﹤0.01% |
+7,613
| New | +$92.7K |
|
2991
Ichor Holdings
ICHR
$2.67B
| $103K | ﹤0.01% |
4,564
+4,558
| +75,967% | +$92.8K |
|
|
PETQ
2992
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $103K | ﹤0.01% |
3,280
+3,279
| +327,900% | +$92.5K |
|
2993
Century Aluminum
CENX
$4.59B
| $103K | ﹤0.01% |
11,598
+10,430
| +893% | +$90.3K |
|
2994
Valvoline
VVV
$4.31B
| $102K | ﹤0.01% |
5,516
+2,187
| +66% | +$43.3K |
|
|
GNC
2995
PUT
DELISTED
GNC Holdings, Inc.
GNC
| $102K | ﹤0.01% |
375
| – | – |
|
|
MTL
2996
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $102K | ﹤0.01% |
51,699
-2,818
| -5% | -$6.37K |
|
|
STML
2997
DELISTED
Stemline Therapeutics, Inc.
STML
| $102K | ﹤0.01% |
+7,957
| New | +$90K |
|
|
CPRX
2998
DELISTED
Catalyst Pharmaceutical
CPRX
| $102K | ﹤0.01% |
+20,042
| New | +$58.9K |
|
|
WLH
2999
DELISTED
WILLIAM LYON HOMES
WLH
| $102K | ﹤0.01% |
+6,639
| New | +$91.6K |
|
3000
Schwab US Large- Cap ETF
SCHX
$75B
| $102K | ﹤0.01% |
9,030
+1,248
| +16% | +$13.5K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.